Oikonomakos N G, Acharya K R, Stuart D I, Melpidou A E, McLaughlin P J, Johnson L N
Laboratory and Molecular Biophysics, Oxford, England.
Eur J Biochem. 1988 May 2;173(3):569-78. doi: 10.1111/j.1432-1033.1988.tb14037.x.
UDP-glucose is an R-state inhibitor of glycogen phosphorylase b, competitive with the substrate, glucose 1-phosphate and noncompetitive with the allosteric activator, AMP. Diffusion of 100 mM UDP-glucose into crystals of phosphorylase b resulted in a difference Fourier synthesis at 0.3-nm resolution that showed two peaks: (a) binding at the allosteric site and (b) binding at the catalytic site. At the allosteric site the whole of the UDP-glucose molecule can be located. It is in a well defined folded conformation with its uracil portion in a similar position to that observed for the adenine of AMP. The uracil and the glucose moieties stack against the aromatic side chains of Tyr-75 and Phe-196, respectively. The phosphates of the pyrophosphate component interact with Arg-242, Arg-309 and Arg-310. At the catalytic site, the glucose-1-P component of UDP-glucose is firmly bound in a position similar to that observed for glucose 1-phosphate. The pyrophosphate is also well located with the glucose phosphate interacting with the main-chain NH groups at the start of the glycine-loop alpha helix and the uridine phosphate interacting through a water molecule with the 5'-phosphate of the cofactor pyridoxal phosphate and with the side chains of residues Tyr-573, Lys-574 and probably Arg-569. However the position of the uridine cannot be located although analysis by thin-layer chromatography showed that no degradation had taken place. Binding of UDP-glucose to the catalytic site promotes extensive conformational changes. The loop 279-288 which links the catalytic site to the nucleoside inhibitor site is displaced and becomes mobile. Concomitant movements of residues His-571, Arg-569, and the loop 378-383, together with the major loop displacement, result in an open channel to the catalytic site. Comparison with other structural results shows that these changes form an essential feature of the T to R transition. They allow formation of the phosphate recognition site at the catalytic site and destroy the nucleoside inhibitor site. Kinetic experiments demonstrate that UDP-glucose activates the enzyme in the presence of high concentrations of the weak activator IMP, because of its ability to decrease the affinity of IMP for the inhibitor site.
UDP-葡萄糖是糖原磷酸化酶b的R态抑制剂,与底物1-磷酸葡萄糖竞争,与变构激活剂AMP非竞争性结合。100 mM UDP-葡萄糖扩散到磷酸化酶b晶体中,产生了分辨率为0.3纳米的差分傅里叶合成图谱,显示出两个峰:(a) 在变构位点结合;(b) 在催化位点结合。在变构位点,可以确定整个UDP-葡萄糖分子的位置。它处于明确的折叠构象,其尿嘧啶部分的位置与AMP的腺嘌呤类似。尿嘧啶和葡萄糖部分分别与Tyr-75和Phe-196的芳香侧链堆积。焦磷酸部分的磷酸与Arg-242、Arg-309和Arg-310相互作用。在催化位点,UDP-葡萄糖的1-磷酸葡萄糖成分紧密结合在与1-磷酸葡萄糖类似的位置。焦磷酸也定位良好,磷酸葡萄糖与甘氨酸环α螺旋起始处的主链NH基团相互作用,尿苷磷酸通过水分子与辅因子磷酸吡哆醛的5'-磷酸以及Tyr-573、Lys-574和可能的Arg-569残基的侧链相互作用。然而,尽管通过薄层色谱分析表明没有发生降解,但尿苷的位置无法确定。UDP-葡萄糖与催化位点的结合促进了广泛的构象变化。连接催化位点与核苷抑制剂位点的279-288环发生位移并变得可移动。His-571、Arg-569残基以及378-383环的伴随运动,连同主要的环位移,形成了通向催化位点的开放通道。与其他结构结果的比较表明,这些变化是T态到R态转变的一个基本特征。它们允许在催化位点形成磷酸识别位点,并破坏核苷抑制剂位点。动力学实验表明,在高浓度弱激活剂IMP存在的情况下,UDP-葡萄糖能激活该酶,因为它能够降低IMP对抑制剂位点 的亲和力。